Common-Size Income Statement
Quarterly Data
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
An analysis of the common-size income statement reveals a period of significant margin expansion followed by a moderate contraction and increased financial volatility. From early 2021 through late 2024, the organization demonstrated a consistent ability to reduce the relative cost of products sold, which drove substantial growth in both gross and operating profit margins. However, the trend shifted in 2025 and 2026, characterized by rising production costs and a notable increase in interest expenses.
- Gross Profitability and Cost Management
- Gross profit margins exhibited a steady upward trajectory from 32.14% in March 2021 to a peak of 38.93% in September 2024. This growth was primarily driven by a sustained reduction in the cost of products sold, which fell from 67.86% to 61.07% over the same period. Following this peak, a reversal occurred; cost of products sold increased to 66.53% by March 2026, causing gross margins to contract to 33.47% before a slight recovery to 34.70% by September 2026.
- Operating Expense Trends
- Selling and administrative expenses remained relatively stable, generally fluctuating between 14% and 17% of net sales. A slight improvement in efficiency is observed in 2025 and 2026, where expenses occasionally dipped to the 14% range. Research and development spending remained highly consistent as a percentage of sales, hovering between 2.66% and 3.41%, indicating a disciplined and steady investment in innovation regardless of fluctuations in overall revenue or gross margin.
- Operating Income and Net Profitability
- Operating income margins showed significant growth, rising from approximately 12% in 2021 to peak levels near 19.6% in late 2024. An anomaly is noted in September 2021, where operating income spiked to 24.70% due to a one-time gain on the sale of a business representing 12.53% of net sales. Net income attributable to ordinary shareholders followed a similar growth pattern, increasing from 9.76% in March 2021 to a high of 16.03% in September 2025. However, a sharp decline to 9.62% was recorded in June 2026 before recovering to 12.05% by the end of the analyzed period.
- Financial Costs and Non-Operating Items
- Interest expense as a percentage of net sales was negligible and stable for several years, typically remaining below 1%. A significant shift occurred in 2026, with interest expenses rising sharply to a peak of 2.36% in June 2026. This increase in financial costs exerted downward pressure on the income before income taxes and net income during the latter part of the period, offsetting some of the operational gains.
Overall, the data indicates a strong operational performance peak between 2023 and 2024, where the combination of lower production costs and stable operating expenses maximized profitability. The subsequent period in 2025 and 2026 suggests a more challenging environment, marked by the erosion of gross margins and a substantial increase in the cost of debt servicing, leading to a compression of the net profit margin.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?